CME Group Inc. (NASDAQ:CME) Shares Bought by Kentucky Retirement Systems Insurance Trust Fund

Kentucky Retirement Systems Insurance Trust Fund lifted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 4.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,163 shares of the financial services provider’s stock after buying an additional 502 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in CME Group were worth $2,592,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC raised its position in shares of CME Group by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after acquiring an additional 142,692 shares in the last quarter. Janus Henderson Group PLC raised its holdings in CME Group by 17.8% during the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock worth $554,707,000 after purchasing an additional 380,071 shares during the last quarter. Franklin Resources Inc. raised its holdings in shares of CME Group by 70.4% in the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after acquiring an additional 1,003,119 shares during the last quarter. Two Sigma Advisers LP increased its stake in CME Group by 11.9% in the third quarter. Two Sigma Advisers LP now owns 2,230,100 shares of the financial services provider’s stock valued at $492,072,000 after purchasing an additional 237,800 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in CME Group by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,981,961 shares of the financial services provider’s stock valued at $437,320,000 after acquiring an additional 26,642 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 1.9 %

Shares of CME opened at $245.48 on Tuesday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $253.53. The stock has a market capitalization of $88.46 billion, a PE ratio of 25.81, a P/E/G ratio of 5.54 and a beta of 0.57. The company’s fifty day moving average is $235.95 and its 200 day moving average is $226.00.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.34% and a return on equity of 13.39%. Sell-side analysts expect that CME Group Inc. will post 10.18 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 annualized dividend and a dividend yield of 2.04%. This is an increase from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio is 48.37%.

CME Group declared that its Board of Directors has authorized a share repurchase plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CME. JPMorgan Chase & Co. upped their price objective on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Barclays raised their price target on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Royal Bank of Canada lifted their target price on CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 13th. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Finally, Oppenheimer boosted their price target on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $234.13.

View Our Latest Analysis on CME Group

Insider Buying and Selling

In other news, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.30% of the stock is owned by corporate insiders.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.